Antibiotic resistance--what can we do? - Suppr | 超能文献

Antibiotic resistance--what can we do?

作者信息

Bax R P, Anderson R, Crew J, Fletcher P, Johnson T, Kaplan E, Knaus B, Kristinsson K, Malek M, Strandberg L

机构信息

SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK.

出版信息

Nat Med. 1998 May;4(5):545-6. doi: 10.1038/nm0598-545.

DOI:10.1038/nm0598-545

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Antibiotic resistance--what can we do?

Nat Med. 1998 May;4(5):545-6. doi: 10.1038/nm0598-545.

2

Hope for the post-antibiotic era?

Nat Biotechnol. 1999 Jan;17(1):20. doi: 10.1038/5189.

3

US vows to combat antibiotic resistance.

Nature. 2014 Sep 25;513(7519):471. doi: 10.1038/513471a.

4

Development of antibiotic resistance: a vet's tale.

J Med Microbiol. 1997 Jan;46(1):26-33.

5

Fighting antibiotic resistance.

Science. 1994 Dec 2;266(5190):1462. doi: 10.1126/science.7985006.

6

The design of clinical trials with antibiotics.

Eur J Clin Microbiol Infect Dis. 1990 Jul;9(7):523-9. doi: 10.1007/BF01964296.

7

[Against preventive antibiotic therapy in neutropenia].

Sangre (Barc). 1994 Jun;39(3):165-6.

8

[Antibiotic pressure and bacterial resistance in the hospital].

Presse Med. 1998 Jun;27 Suppl 3:5-14.

9

Antimicrobial resistance: insights into control and treatment of complicated infections. Introduction.

Pharmacotherapy. 2005 Oct;25(10 Pt 2):41S-43S. doi: 10.1592/phco.2005.25.10part2.41S.

10

Canadian scientists urge government to develop antibiotic plan.

Lancet. 2002 Oct 19;360(9341):1230. doi: 10.1016/S0140-6736(02)11302-X.

引用本文的文献

1

MACRO SOLUTIONS TO A MICRO PROBLEM: DRUG-RESISTANT PNEUMOCOCCAL PNEUMONIA.

Trans Am Clin Climatol Assoc. 2025;135:393-402.

2

A novel approach for the synthesis of the cyclic lipopeptide globomycin.

RSC Med Chem. 2024 Oct 21;16(1):373-8. doi: 10.1039/d4md00685b.

3

A qualitative study on community use of antibiotics in Kinshasa, Democratic Republic of Congo.

PLoS One. 2022 Apr 27;17(4):e0267544. doi: 10.1371/journal.pone.0267544. eCollection 2022.

4

Bacterial Natural Product Drug Discovery for New Antibiotics: Strategies for Tackling the Problem of Antibiotic Resistance by Efficient Bioprospecting.

Antibiotics (Basel). 2021 Jul 10;10(7):842. doi: 10.3390/antibiotics10070842.

5

Community knowledge and practices regarding antibiotic use in rural Mozambique: where is the starting point for prevention of antibiotic resistance?

BMC Public Health. 2020 Jul 29;20(1):1183. doi: 10.1186/s12889-020-09243-x.

6

Identification of the Molecular Determinants Involved in Antimicrobial Activity of Pseudodesmin A, a Cyclic Lipopeptide From the Viscosin Group.

Front Microbiol. 2020 Apr 21;11:646. doi: 10.3389/fmicb.2020.00646. eCollection 2020.

7

Detecting and prioritizing biosynthetic gene clusters for bioactive compounds in bacteria and fungi.

Appl Microbiol Biotechnol. 2019 Apr;103(8):3277-3287. doi: 10.1007/s00253-019-09708-z. Epub 2019 Mar 12.

8

Bacteria of the Genus , a Novel Source of Bioactive Compounds.

Front Microbiol. 2018 Dec 19;9:3177. doi: 10.3389/fmicb.2018.03177. eCollection 2018.

9

MDAD: A Special Resource for Microbe-Drug Associations.

Front Cell Infect Microbiol. 2018 Dec 7;8:424. doi: 10.3389/fcimb.2018.00424. eCollection 2018.

10

A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier?

Front Microbiol. 2018 Sep 28;9:2297. doi: 10.3389/fmicb.2018.02297. eCollection 2018.